Induction Study for Ulcerative Colitis
Research on a medication aimed at patients with active Ulcerative Colitis who have not responded to conventional or biologic therapies.
Principal Investigator: Dr. Mrinal Garg, MD
Call us when you need help(954) 302-3047Research on a medication aimed at patients with active Ulcerative Colitis who have not responded to conventional or biologic therapies.
Ongoing study on the efficacy of a maintenance medication for patients with active Ulcerative Colitis.
Evaluation of the efficacy and safety of a medication in patients with active Crohn's Disease.
Study on medication efficacy in patients with active Crohn's Disease who have not responded to or are intolerant of biologic therapies.
Clinical study assessing medication for Crohn's Disease patients who have not responded to conventional and/or biologic therapies.
Investigation of long-term effects and maintenance of medication in Crohn's Disease patients who have completed previous studies.
Study focused on achieving and maintaining remission in patients with active Crohn's Disease.
An ongoing, extended study to assess the long-term impact of a medication in Crohn's Disease patients.
Dr. Mrinal Garg is a dedicated gastroenterologist at the Digestive Health Center of South Florida, Broward Specialty Center, where he is a partner in the practice. He earned his medical degree from New York Medical College, followed by an Internal Medicine residency at the University of Medicine and Dentistry of New Jersey. Dr. Garg then completed a fellowship in Gastroenterology at Allegheny Health Network in Pennsylvania. Since 2002, he has actively participated in clinical research and currently serves as a Principal Investigator and Sub-Investigator in five clinical studies.

Call us to be added to our database, or send your information through the contact page and one of our physicians will call you back to determine whether you may qualify.
Get notified when new clinical trials are announced.